Issue: Exclusive Online Content, Posted Date: 2/3/2017

SiO2 Medical Products, Inc. Receives Marketing Authorization for Filled 6-mL Vials

SiO2 Medical Products, Inc. (SMP) received marketing authorization (MA) for the Type II variation of the primary packaging of zoledronic acid from the German Medicines Authority BfArM on November 25, 2016. The drug, zoledronic acid, is packaged in a proprietary 6-mL vial developed by SMP. The proprietary 6-mL vial incorporates a silicon-based barrier coating system that combines the durability, pH stability, and dimensional consistency of an engineered polymer (such as a cyclic olefin polymer) with the barrier properties and low extractables of silica glass. This unique packaging solution may provide an ideal primary container for a myriad of pharmaceutical or biologic therapies – including zoledronic acid.


The marketing authorization application was submitted on August 22, 2016, to the German authorities detailing a product filing for a Type II variation of an existing marketing authorization. Accompanying the submission was a 6-month formal stability study and leachable testing. SMP anticipates a similar approach for marketing authorization of other pharmaceutical or biologic therapies in its proprietary primary containers.


For more information regarding the submission and SiO2 Medical Products, Inc.’s platform of products, please contact


About SiO2 Medical Products, Inc.

SiO2 Medical Products, Inc. designs, develops, manufactures, and supplies precision-molded primary containers, labware, and consumable products molded from medical grade engineered polymers, such as cyclic olefin polymer. These unique products incorporate thin, transparent coatings or treatments on the drug contact surfaces to provide the best qualities of both standard plastic and glass containers, without their respective drawbacks. The company is headquartered in Auburn, Alabama, with sales, marketing, legal, and project management capabilities based out of offices near Philadelphia, PA.

This record has been viewed 767 times.


Click here to see the showcases

BIO Investor Forum
October 17-18, 2017
The Westin St. Francis, San Francisco, CA US
Partnership Opportunities in Drug Delivery (PODD)
October 19-20
Boston, MA

CPhI Worldwide
October 24-26
Frankfurt, Germany

Universe of Prefilled Syringes & Injection Devices Europe
November 7-8
Vienna, Austria

November 12-17
San Diego, CA

Pre-Filled Syringes Europe
January 17-18, 2018
Copthorne Tara Hotel, London UK

Drug Delivery Partnerships
January 22-24 Palm Beach, FL

3rd Annual Drug Development Networking Summit
March 8, 2018  Hilton Hotel Parsippany NJ
PDA Annual Meeting
March 19-21 Orlando, FL
CPhI North America
April 24-26 Philadelphia, PA 
April 17-19 New York City
RDD (Respiratory Drug Delivery)
April 22-26 Tucson, AZ
BIO 2018
June 4-7 Boston, MA
Controlled Release Society Meeting
July 23-25 New York City
Universe of Prefilled Syringes & Injection Devices
October 8-9 Orlando, FL

Copyright © 2017  Drug Development & Delivery All Rights Reserved. Privacy Policy / Terms and Conditions